Published in Front Microbiol on April 28, 2015
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA). World J Emerg Surg (2016) 1.55
Antimicrobial Activity and Phytochemical Analysis of Organic Extracts from Cleome spinosa Jaqc. Front Microbiol (2016) 1.41
Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives. Medchemcomm (2015) 0.82
One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams. Protein Sci (2016) 0.82
Antimicrobial Drugs in Fighting against Antimicrobial Resistance. Front Microbiol (2016) 0.79
The Three Bacterial Lines of Defense against Antimicrobial Agents. Int J Mol Sci (2015) 0.79
Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa. Front Microbiol (2016) 0.78
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front Cell Infect Microbiol (2017) 0.76
Multiple roles for a novel RND-type efflux system in Acinetobacter baumannii AB5075. Microbiologyopen (2016) 0.76
Quorum-Sensing Mechanisms and Bacterial Response to Antibiotics in P. aeruginosa. Curr Microbiol (2016) 0.76
Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli. PeerJ (2017) 0.75
Efflux Pump Blockers in Gram-Negative Bacteria: The New Generation of Hydantoin Based-Modulators to Improve Antibiotic Activity. Front Microbiol (2016) 0.75
E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance. Front Microbiol (2017) 0.75
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature (2006) 5.35
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother (2001) 5.23
Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol (2006) 5.18
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev (2006) 4.77
Bacterial heavy metal resistance: new surprises. Annu Rev Microbiol (1996) 4.28
Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science (2006) 4.21
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J Bacteriol (1997) 3.81
Efflux-mediated multiresistance in Gram-negative bacteria. Clin Microbiol Infect (2004) 3.71
Efflux-mediated antimicrobial resistance. J Antimicrob Chemother (2005) 3.69
Mechanisms of solvent tolerance in gram-negative bacteria. Annu Rev Microbiol (2002) 3.50
Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol (1997) 3.21
Pseudomonas aeruginosa: resistance to the max. Front Microbiol (2011) 2.76
Mechanisms of RND multidrug efflux pumps. Biochim Biophys Acta (2008) 2.60
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev (2011) 2.46
Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J Exp Med (2002) 2.40
Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science (2011) 2.26
Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol Microbiol (2003) 2.18
Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Biochem Pharmacol (2006) 2.14
Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob Agents Chemother (2002) 1.96
Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature (2011) 1.89
Sequential mechanism of assembly of multidrug efflux pump AcrAB-TolC. Chem Biol (2011) 1.82
Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB. Nat Struct Mol Biol (2008) 1.81
Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev (2009) 1.79
Drug transport mechanism of the AcrB efflux pump. Biochim Biophys Acta (2009) 1.76
Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc Natl Acad Sci U S A (2012) 1.66
Structure of the AcrAB-TolC multidrug efflux pump. Nature (2014) 1.66
Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother (2006) 1.65
Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB. J Bacteriol (2008) 1.63
Antibiotics in the clinical pipeline in 2011. J Antibiot (Tokyo) (2011) 1.62
The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol Microbiol (1999) 1.61
New antibiotics for bad bugs: where are we? Ann Clin Microbiol Antimicrob (2013) 1.58
Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat Rev Drug Discov (2006) 1.55
Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol (2005) 1.54
Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis. J Clin Microbiol (2005) 1.49
Multidrug efflux transporter, AcrB--the pumping mechanism. Curr Opin Struct Biol (2008) 1.42
Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins. J Bacteriol (2007) 1.36
Mechanism and Function of the Outer Membrane Channel TolC in Multidrug Resistance and Physiology of Enterobacteria. Front Microbiol (2011) 1.35
Bacterial efflux systems and efflux pumps inhibitors. Biochimie (2005) 1.35
Assembly and transport mechanism of tripartite drug efflux systems. Biochim Biophys Acta (2009) 1.31
Structural basis for the inhibition of bacterial multidrug exporters. Nature (2013) 1.31
Structure and mechanism of RND-type multidrug efflux pumps. Adv Enzymol Relat Areas Mol Biol (2011) 1.30
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrob Agents Chemother (2010) 1.30
Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J (2003) 1.28
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother (2005) 1.26
Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrob Agents Chemother (2009) 1.26
An ABC transporter with a secondary-active multidrug translocator domain. Nature (2003) 1.21
The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR. Proc Natl Acad Sci U S A (2008) 1.20
Fitting periplasmic membrane fusion proteins to inner membrane transporters: mutations that enable Escherichia coli AcrA to function with Pseudomonas aeruginosa MexB. J Bacteriol (2007) 1.19
High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control (2003) 1.18
The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother (2005) 1.17
Identification of host-induced pathogen genes by differential fluorescence induction reporter systems. Nat Protoc (2007) 1.16
Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ. J Med Chem (2005) 1.14
RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr Top Med Chem (2013) 1.14
Identification of transport proteins involved in free fatty acid efflux in Escherichia coli. J Bacteriol (2012) 1.09
Solvent tolerance in Gram-negative bacteria. Curr Opin Biotechnol (2011) 1.09
The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance. Curr Drug Targets (2008) 1.09
Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother (2012) 1.08
An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol Microbiol (2002) 1.08
Bacterial multidrug efflux transporters. Annu Rev Biophys (2014) 1.08
Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance. Proc Natl Acad Sci U S A (2012) 1.07
Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob Agents Chemother (2014) 1.05
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance. Antimicrob Agents Chemother (2008) 1.03
Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. Int J Antimicrob Agents (2010) 0.96
Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother (2004) 0.96
Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob Agents Chemother (2013) 0.95
Promiscuous partnering and independent activity of MexB, the multidrug transporter protein from Pseudomonas aeruginosa. Biochem J (2010) 0.94
Bacterial efflux pumps involved in multidrug resistance and their inhibitors: rejuvinating the antimicrobial chemotherapy. Recent Pat Antiinfect Drug Discov (2012) 0.94
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. Farmaco (2001) 0.93
Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infect (2007) 0.93
Inhibition of multidrug efflux as a strategy to prevent biofilm formation. J Antimicrob Chemother (2013) 0.93
Towards understanding promiscuity in multidrug efflux pumps. Trends Biochem Sci (2013) 0.92
Structural and functional aspects of the multidrug efflux pump AcrB. Biol Chem (2009) 0.92
Non-antibiotics reverse resistance of bacteria to antibiotics. In Vivo (2010) 0.92
Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. J Antimicrob Chemother (2010) 0.92
Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ. PLoS One (2013) 0.89
Artesunate enhances the antibacterial effect of {beta}-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC. J Antimicrob Chemother (2011) 0.89
Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Int J Antimicrob Agents (2009) 0.88
Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli. J Antimicrob Chemother (2011) 0.88
Molecular Dynamics Computer Simulations of Multidrug RND Efflux Pumps. Comput Struct Biotechnol J (2013) 0.87
Expression of homologous RND efflux pump genes is dependent upon AcrB expression: implications for efflux and virulence inhibitor design. J Antimicrob Chemother (2014) 0.86
Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them. Front Pharmacol (2014) 0.86
Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa. Microbiology (2013) 0.85
Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter. Antimicrob Agents Chemother (2014) 0.84
Effect of the proton motive force inhibitor carbonyl cyanide-m-chlorophenylhydrazone (CCCP) on Pseudomonas aeruginosa biofilm development. Lett Appl Microbiol (2008) 0.84
Pimozide Inhibits the AcrAB-TolC Efflux Pump in Escherichia coli. Open Microbiol J (2013) 0.81
Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. Int J Antimicrob Agents (2006) 0.80
Regulation of RamA by RamR in Salmonella enterica serovar Typhimurium: isolation of a RamR superrepressor. Antimicrob Agents Chemother (2012) 0.79
Mutations in MexB that affect the efflux of antibiotics with cytoplasmic targets. FEMS Microbiol Lett (2012) 0.79
Understanding the basis of antibiotic resistance: a platform for drug discovery. Microbiology (2014) 0.79
Possible Role of Curcumin as an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa. J Clin Diagn Res (2014) 0.79
Evaluation and target validation of indole derivatives as inhibitors of the AcrAB-TolC efflux pump. Biosci Biotechnol Biochem (2010) 0.78
An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates. Microbiology (2010) 0.78
Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in Campylobacter spp. isolates. Microb Drug Resist (2012) 0.78
AmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa. Microbiologyopen (2014) 0.78
Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Microbiologyopen (2014) 0.78
Pharmacophore generation of 2-substituted benzothiazoles as AdeABC efflux pump inhibitors in A. baumannii. SAR QSAR Environ Res (2014) 0.77
Pentachlorophenol induction of the Pseudomonas aeruginosa mexAB-oprM efflux operon: involvement of repressors NalC and MexR and the antirepressor ArmR. PLoS One (2012) 0.77
Enhancement of the antibiotic activity of aminoglycosides by alpha-tocopherol and other cholesterol derivates. Biomed Pharmacother (2014) 0.77